Laureate Education, Inc. · NASDAQ:LAUR

Laureate Education — FY2006 Earnings Presentation

6 slides from Laureate Education's earnings presentation, Mar 1, 2007

  1. Slide 1: Laureate Education

    LAUREATE ED UGA T IO NIPENIC

  2. Slide 2: 2006 Performance vs. Guidance

    1 2006 Performance vs. Guidance ($ in millions, except per EPS) Minority Share As Purchase ($ in millions, except EPS) 2006 Guidance (A) Reported Agreement ProForma Revenue LATAM $670 - $680 $687 $687 Europe $210 - $220 $224 $224 Campus-Based $880 - $900 $911 $911 Online $230 -$235 $235 $235 Total R

  3. Slide 3: 2007 Guidance

    2 2007 Guidance ($in millions, except EPS) Guidance Guidance 1Q 2007 FY 2007 Revenue LATAM $130 - $145 $760 - $805 Europe $70 - $75 $240 - $265 Campus-Based $200 - $220 $1,000 - $1,070 Online $65 - $70 $275 - $305 Total Revenue: $265 - $290 $1,275 - $1,375 Total Enrollment Campus-Based Total 11% - 1

  4. Slide 4: Example: Recording the Charge

    3 Minority Share Purchase Agreement Example: Recording the Charge EXAMPLE -- FOR ILLUSTRATIVE PURPOSES When evaluating a minority interest put option: Step 1: Calculate current value of the 10% Put option $55.0 Step 2: Compare value of the Put option to the recorded Minority Interest liability on th

  5. Slide 5: Example: Impact when the Put is Exercised

    4 Minority Share Purchase Agreement ($ in millions, except EPS) Example: Impact when the Put is Exercised Conclusion: The impact to EPS associated with ASR 268 results in timing differences, as reductions taken to EPS will be offset once the Company purchases the minority partner's shares. EXAMPLE -

  6. Slide 6: Reconciliation of GAAP to Adjusted Results

    5 Reconciliation of GAAP to Adjusted Results Non-GAAP Financial Measures Today’s earnings release contains certain non-GAAP financial measures. Management believes these non- GAAP items provide useful information to management and investors by excluding certain items that may not be indicative of th

Laureate Education — FY2006 Earnings Presentation on 6ix